Skip to main content

Recently Updated Pages

App Development Plan

Development Plan

Biometrics ITEM STATUS LOGS Study Designer ...

Updated 6 months ago by Colin Wang

ICH E20 Adatpative Designs for Clinical Trials

ICH ICH E20

1. INTRODUCTION AND SCOPE This document provides guidance on confirmatory clinical trials with an...

Updated 8 months ago by Colin Wang

罕见疾病药物临床研究统计学指导原则(试行)

Biostatistics NMPA

一、概述 与常见疾病相比,罕见疾病及其药物研发具有以下特点:①罕见疾病中很多是严重或危及生命的疾病,许多属于先天遗传性疾病且多始发于儿童期;②对于罕见疾病,通常流行病学和疾病自然史等数据...

Updated 8 months ago by Colin Wang

抗肿瘤药物临床试验统计学设计指导原则(试行)

Biostatistics NMPA

一、概述 与其他治疗领域一样,抗肿瘤药物在进入临床试验前,应该有足够的基于临床前实验或既往人体试验的科学证据显示某(些)剂量的试验药物在目标人群的安全性。临床试验的主要目的是针对药物研发...

Updated 8 months ago by Colin Wang

Contributors List

Community Contributors

IoC E Eric ZHANG, Ph.D, MBA School of Mathematics, Tsinghua...

Updated 8 months ago by Colin Wang

基于疾病登记的真实世界数据应用指导原则(试行)

Biostatistics NMPA

一、引言 使用真实世界证据( real-world evidence , RWE )支持药物监管决策日益受到重视。目前,开展真实世界研究( real-world study , RWS ...

Updated 8 months ago by Colin Wang

针对泛肿瘤的抗肿瘤药物临床研发技术指导原则

General NMPA

一、背景 传统的临床实践主要基于肿瘤的原发部位和病理组织学分型进行诊断、判断预后以及支持治疗决策。分子生物学和免疫学的研究进步推动了对肿瘤关键异常分子改变的发现,从而改变了医学界对肿瘤的全面认识...

Updated 8 months ago by Colin Wang

Best Practice for Materials Consumption Simulator

Material Consumption Simulator Best Practice

Updated 8 months ago by Colin Wang

物料消耗模拟器用户指南

Material Consumption Simulator User Manual

English Version User Manual for Materials Consumption Simulator 物料消耗模拟器 物料消耗模拟器 1. 为什...

Updated 8 months ago by Colin Wang

物料消耗模拟器实用案例

Material Consumption Simulator Best Practice

Updated 8 months ago by Colin Wang

User Manual for Materials Consumption Simulator

Material Consumption Simulator User Manual

中文版 物料消耗模拟器用户指南 Materials Consumption Simulator Materials Consumption Simulator 1. Wh...

Updated 8 months ago by Colin Wang

App Repository

App Repository

中文版 软件库 Others Online ...

Updated 8 months ago by Colin Wang

软件库

App Repository

English Version Software Repository Others ...

Updated 8 months ago by Colin Wang

单臂临床试验用于支持抗肿瘤药物常规上市申请技术指导原则

General NMPA

一、概述 单臂临床试验(single arm trial,SAT)是不设立平行对照,采用开放设计,不涉及随机与盲法的一种临床试验设计。 在抗肿瘤治疗领域,为了推动新药及早上市,解决患者未满足的临...

Updated 8 months ago by Colin Wang

A Review of Clinical Pharmacology Considerations in Antibody-drug Conjugates Approved by the US Food and Drug Administration Between 2000 and 2025

Fun Fact ADC

by Seoyoung Koo, Chae Yeon Kim, Jeong-hyeon Lim, Eunyoung Lee, In Young Kim, Young G. Shin, and H...

Updated 8 months ago by Colin Wang

Modified Fibonacci Sequence

Dose Escalation Math in Dose Escalation

Fibonacci Sequence The classic Fibonacci sequence is defined by the linear recurrence equation: ...

Updated 8 months ago by Colin Wang

Authors List

Community Authors

IoC C Colin WANG, Ph.D School of Mathematical Sciences, Uni...

Updated 8 months ago by Colin Wang

Trial Users List

Community Trial Users

IoC

Updated 8 months ago by Colin Wang

药物临床试验数据递交指导原则(试行)

Biostatistics NMPA

一、背景与目的 药物临床试验数据是申办方向监管机构递交的重要资料之一,对于监管机构和申办方来说都是宝贵的资源。规范地收集、整理、分析和呈现临床试验数据对于提高药物临床研发的效率和质量、缩短审评时...

Updated 8 months ago by Colin Wang

药物临床试验样本量估计指导原则(试行)

Biostatistics NMPA

一、 概述 样本量估计,又称样本量确定,是药物临床试验设计的重要组成部分,也是确保研究具有合理性、准确性、可靠性、完整性和科学性的重要手段。通常,临床试验的样本要有充分的代表性,纳入的样本量必须...

Updated 9 months ago by Colin Wang